SUTUREGARD^® MEDICAL INC. Blog

Bill Lear, MD, Mohs surgeon now but 5-year emergency physician previously, talks with Dr. Mark Plaster of Emergency Physician Monthly about how being an ER doc nurtured his inventive skills which eventually led to his development of the HEMIGARD ARS device. The HEMIGARD ARS device manages lateral wound tension to close excisions, lacerations, and incisions in fragile or high tension or at-risk wounds. 

SUTUREGARD® Medical has formed a non-exclusive distribution partnership with Federated Healthcare Supply to expand market reach of the HEMIGARD® ARS device and the SUTUREGARD® ISR device which are patented wound closure technologies that simplify complex and challenging wound closures.

"When I want to eliminate patient post-op visits for suture removal, I have been using the HEMIGARD device with the retention suture, followed by deeps and top fast gut sutures." Stephanie Howerter, DO, FACMS

First, let’s back up. Tissue is sent for pathology to answer one of two questions: “what is it?” or “did I get it all?” The question of “what is it?” is answered with the initial sampling, or biopsy. A piece of skin (or other tissue) is removed from a patient, preserved (or “fixed”) in formalin, sliced into thin pieces, stained so that cellular detail can be seen and then examined under the microscope. In dermatology, biopsies are performed to diagnose rashes as well as to evaluate for ...

Usually, excisional wounds are created with an ellipse: where the length of the wound is about 2-4 times longer than the width. This allows the wound to be closed without “bunching” of the ends. When closing these elliptical wounds, the initial suture is usually placed in the middle, widest and most difficult portion of the wound to close. This is known as the rule of halves:

Newly published research in the Journal of Clinical Biomechanics supports using novel devices, such as the SUTUREGARD® ISR Retention Suture Device and the HEMIGARD™ Adhesive Retention Suture Device, to initiate approximation of high-tension surgical wounds. Learn more about Suturegard devices!

Mohs surgery relies on processing tissue. The tumor is removed but then it is studied & laid down to map out the tissue. This tissue is then frozen & thin sections are created to be viewed in a machine where cells can be seen. If you want to learn more about Mohs Surgery & how it works read more.

SUTUREGARD® Medical, Inc is pleased to announce that it will be presenting at the MEDICA International Trade Fair. The fair, which runs from 18 to 21 November in Düsseldorf, Germany, will present a platform for more than 5,000 exhibitors to display innovative products and ideas. It is a vital opportunity for the company to showcase the SUTUREGARD® ISR Retention Suture Device, a patented technology that aids in surgical closure of high-tension wounds through rapid tissue expansion.

By: Dan Ladizinsky, MD, CEO, SUTUREGARD Medical, Retired Board Certification in General Surgery, Plastic Surgery, with Certificate of Added Qualifications in Surgery of the Hand, Former Fellow of the American College of Surgeons. Undermining is a surgical technique that mechanically separates the skin & superficial subcutaneous fat as one layer, away from its underlying soft tissues. Undermining can be done in a superficial or deep subcutaneous plane if you want to learn more about why not to us...

A basal cell carcinoma (BCC) is one of the most common skin cancers. Every year, there are over 4 million BCC diagnosed in the United States. While BCC is very common, it rarely spreads to internal organs or lymph nodes. However, it can be locally destructive and invade the tissue around it.